Finkelstein Thompson LLP announces that it is investigating potential claims on behalf of shareholders of AthenaHealth, Inc. (NASDAQ: ATHN)

On February 25, 2010, AthenaHealth issued a press release announcing that it would postpone its fourth-quarter earnings in order to conduct an internal accounting policy review. Since the Company’s announcement, AthenaHealth shares have plunged more than 15% on approximately double its average daily volume of shares traded. This announcement follows an earlier statement issued by the Company on February 4, 2010 that AthenaHealth was revising its calculation of 2009 earnings due to accounting issues related to how
the Company reported net income on a non-GAAP basis.

One analyst following AthenaHealth has estimated that the accounting issues may lead the Company to restate “implementation revenue” by approximately $2 million annually and that AthenaHealth may have to restate earnings as far back as 2006. A recent report in Barron’s has also noted that certain company insiders have sold more than $25 million in stock over the past 12 months.

If you are interested in discussing your rights as an AthenaHealth shareholder, or have information relating to this investigation, please
contact Finkelstein Thompson's Washington, D.C. offices at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it